Home Mf Research Aditya Birla Sun Life Pharma Healthcare Fund Regular Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
Fund info
NAV (as on 2026-08-21)
₹36.43 -0.33%
AUM (Fund Size)
950.31 Cr
Expense Ratio
N/A
Exit load
N/A
Risk
Very High
AMC
Aditya Birla Sun Life Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-08-14 ₹1,000.00 ₹993.18
-0.68 %
Two Week 2026-08-06 ₹1,000.00 ₹998.36
-0.16 %
One Month 2026-07-22 ₹1,000.00 ₹1,017.03
1.70 %
Three Months 2026-05-25 ₹3,000.00 ₹3,163.73
5.46 %
Six Months 2026-02-23 ₹6,000.00 ₹6,702.96
11.72 %
One Year 2025-08-21 ₹12,000.00 ₹13,795.39
14.96 %
Three Year 2023-08-22 ₹36,000.00 ₹46,415.31
28.93 %
Five Year 2021-08-23 ₹60,000.00 ₹96,132.05
60.22 %
Since Inception 2019-07-10 ₹87,000.00 ₹169,731.32
95.09 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Other
100.02%

Companies Holding in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Sun Pharmaceutical Industries Limited
12.42%
Torrent Pharmaceuticals Limited
4.76%
J.B. Chemicals & Pharmaceuticals Limited
4.73%
Aurobindo Pharma Limited
4.37%
Ajanta Pharmaceuticals Limited
3.99%
Mankind Pharma Ltd
3.89%
Lupin Limited
3.73%
Abbott India Limited
3.67%
Emcure Pharmaceuticals Ltd
3.17%
Cipla Limited
2.98%
Shilpa Medicare Ltd
2.92%
IPCA Laboratories Limited
2.43%
SAI Life Sciences Ltd
2.26%
Procter & Gamble Health Limited
2.24%
CORONA Remedies Ltd
2.06%
Alkem Laboratories Limited
2.03%
Divi's Laboratories Limited
1.82%
SANOFI CONSUMER HEALTHCARE
1.52%
Pfizer Limited
1.36%
Dr. Reddys Laboratories Limited
1.36%
ALEMBIC PHARMACEUTICALS LIMITED
1.25%
Biocon Limited
1.23%
Gland Pharma Limited
1.20%
Piramal Pharma Ltd
1.16%
ANTHEM BIOSCIENCES LIMITED
1.13%
GlaxoSmithKline Pharmaceuticals Limited
0.75%
Jubilant Pharmova Ltd
0.66%
Apollo Hospitals Enterprise Limited
7.31%
Fortis Healthcare Limited
3.31%
Thyrocare Technologies Limited
1.89%
Jupiter Life Line Hospitals Ltd
1.84%
METROPOLIS HEALTHCARE LIMITED
1.57%
Dr. Lal Path Labs Limited
1.38%
Vijaya Diagnostic Centre Limited
1.08%
Suraksha Diagnostic Ltd
1.01%
Max Healthcare Institute Limited
0.71%
Medi Assist Healthcare Services Ltd
1.01%
Vinati Organics Limited
0.65%
Net Cash And Cash Equivalent
3.17%

Risk Ratios

Std. Deviation 16.13%
Beta 0.92
Sharpe Ratio 1.13
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Objective

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There is no assurance that the objective of the Scheme will be achieved

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
N/A
Expense Ratio Direct
N/A
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare
Fund managers
Dhaval Shah
6 Years Experience

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?